Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 2 | Lipids in Health and Disease

Fig. 2

From: Druggable genome-wide Mendelian randomization identifies therapeutic targets for metabolic dysfunction-associated steatotic liver disease

Fig. 2

Regional Manhattan plot of associations between SNPs and MFGE8 and CD33 locus. (A) rs10520679 was used to proxy serum MFGE8 expression. (B) rs10520679 and its flanking 500 kb region to either side in MASLD. (C) rs1710398 was used to proxy serum CD33 expression. (D) rs1710398 and its flanking 500 kb region to either side in MASLD. MASLD, metabolic dysfunction associated steatotic liver disease; MFGE8, milk fat globule-EGF factor 8; SNP, single-nucleotide polymorphisms

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X